Comparative antitumor efficacy of docetaxel and paclitaxel in nude mice bearing human tumor xenografts that overexpress the multidrug resistance protein (MRP)
1997 · Annals of Oncology · 72 citations
https://doi.org/10.1023/a:1008290406221
S
S. Seeber
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
442
Papers
12.1K
Citations
51
h-index
200
i10-index
S. Seeber is an academic researcher from Universitätsklinikum Knappschaftskrankenhaus Bochum. The author has contributed to research in topics: Cancer Treatment and Pharmacology & Chronic Lymphocytic Leukemia Research & Cancer therapeutics and mechanisms. The author has an h-index of 51, co-authored 376 publications.
Papers by this author
worksCarbamoylation of glutathione reductase by n,n-bis(2-chloroethyl)-n-nitrosourea associated with inhibition of multidrug resistance protein (MRP) function
1997 · Biochemical Pharmacology · 34 citations
https://doi.org/10.1016/s0006-2952(97)00010-5
Survival of tumor cells in stem cell preparations and bone marrow of patients with high-risk or metastatic breast cancer after receiving dose-intensive or high-dose chemotherapy.
2001 · PubMed · 31 citations
Reversal of MDR1-associated resistance to topotecan by PAK-200S, a new dihydropyridine analogue, in human cancer cell lines
1999 · British Journal of Cancer · 26 citations
https://doi.org/10.1038/sj.bjc.6694384
Improved survival in metastatic breast cancer: results from a 20-year study involving 1033 women treated at a single comprehensive cancer center
2020 · Journal of Cancer Research and Clinical Oncology · 20 citations
https://doi.org/10.1007/s00432-020-03184-z
Rare expression of target antigens for immunotherapy on disseminated tumor cells in breast cancer patients without overt metastases
2003 · International Journal of Molecular Medicine · 9 citations
https://doi.org/10.3892/ijmm.12.6.969
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat